Published in Biochem Biophys Res Commun on February 25, 2010
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28
Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem (2011) 1.98
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol (2011) 1.72
Treatment of Neuromyelitis Optica: Review and Recommendations. Mult Scler Relat Disord (2012) 1.62
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol (2014) 1.60
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
Aquaporin 4 molecular mimicry and implications for neuromyelitis optica. J Neuroimmunol (2013) 1.42
Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol (2014) 1.38
Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One (2011) 1.38
Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica. PLoS One (2011) 1.13
The innate immune system in demyelinating disease. Immunol Rev (2012) 1.10
Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation (2012) 1.09
Absence of cortical demyelination in neuromyelitis optica. Neurology (2010) 1.07
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci (2015) 1.07
Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol (2012) 1.04
Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol (2015) 1.00
Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol (2013) 0.96
Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG. Acta Neuropathol (2013) 0.95
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica. Acta Neuropathol Commun (2015) 0.93
Molecular pathogenesis of neuromyelitis optica. Int J Mol Sci (2012) 0.92
Experimental models of neuromyelitis optica. Brain Pathol (2014) 0.86
Autoimmune epilepsies. Neurotherapeutics (2014) 0.86
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun (2014) 0.85
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica. PLoS One (2013) 0.82
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica. J Neuroinflammation (2016) 0.79
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. BMC Neurol (2013) 0.79
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO? Mult Scler Int (2012) 0.78
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun (2015) 0.78
Review of Animal Models of Neuromyelitis Optica. Mult Scler Relat Disord (2012) 0.77
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis. Front Neurol (2014) 0.75
Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System. Front Immunol (2017) 0.75
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest (2004) 4.04
Osteoprotection by semaphorin 3A. Nature (2012) 3.40
FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci (2005) 2.87
Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol (2006) 2.57
Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol (2004) 2.39
Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev (2004) 2.22
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun (2009) 2.20
Semaphorins and their receptors in immune cell interactions. Nat Immunol (2007) 2.07
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet (2005) 2.07
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature (2002) 2.04
SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. Neuron (2011) 2.03
The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function. Immunity (2012) 1.98
Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature (2007) 1.87
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A (2007) 1.83
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis. Nat Med (2011) 1.71
Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest (2013) 1.68
Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci (2008) 1.64
Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells (2007) 1.57
Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med (2012) 1.55
Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J Med Virol (2004) 1.55
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med (2008) 1.53
Role of the prefrontal cortex in human balance control. Neuroimage (2008) 1.48
The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci (2003) 1.46
Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction. Stem Cells (2009) 1.42
Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells. Dev Biol (2008) 1.36
Structural basis for semaphorin signalling through the plexin receptor. Nature (2010) 1.33
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol (2010) 1.33
Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling. J Gen Physiol (2007) 1.30
Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells (2010) 1.30
Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol (2003) 1.28
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J (2007) 1.28
The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog (2010) 1.26
A midline switch of receptor processing regulates commissural axon guidance in vertebrates. Genes Dev (2010) 1.25
Dynamics of coupled vortices in a pair of ferromagnetic disks. Phys Rev Lett (2011) 1.25
Bimodal regulation of T cell-mediated immune responses by TIM-4. Int Immunol (2008) 1.23
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung. Clin Cancer Res (2011) 1.22
Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur J Neurosci (2004) 1.21
Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol (2012) 1.20
Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport (2009) 1.19
Mammalian E4 is required for cardiac development and maintenance of the nervous system. Mol Cell Biol (2005) 1.17
Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc Natl Acad Sci U S A (2009) 1.15
Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci (2011) 1.14
A novel method for systematic analysis of rigidity in Parkinson's disease. Mov Disord (2009) 1.14
Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus. J Biol Chem (2004) 1.14
Roles of Sema4D and Plexin-B1 in tumor progression. Mol Cancer (2010) 1.13
Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. Development (2005) 1.12
Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. J Biol Chem (2009) 1.11
Ischemia-induced neural stem/progenitor cells in the pia mater following cortical infarction. Stem Cells Dev (2011) 1.11
Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing. Neuron (2012) 1.08
Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol (2010) 1.08
Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. Neuroreport (2002) 1.08
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol (2003) 1.07
Isolation and characterization of neural stem/progenitor cells from post-stroke cerebral cortex in mice. Eur J Neurosci (2009) 1.07
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol (2010) 1.06
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer. J Transl Med (2013) 1.06
Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population. Neuroreport (2007) 1.05
Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum Mol Genet (2008) 1.05
Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS One (2012) 1.05
Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood (2010) 1.05
Immune semaphorins: novel features of neural guidance molecules. J Clin Immunol (2008) 1.04
Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr Pathol (2008) 1.04
Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease. Hypertens Res (2009) 1.04
Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27(Kip1). Glia (2002) 1.04
Evolution of the spin Hall effect in Pt nanowires: size and temperature effects. Phys Rev Lett (2007) 1.03
New mutation of the Na channel in the severe form of potassium-aggravated myotonia. Muscle Nerve (2009) 1.03
Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin. J Immunol (2011) 1.02
Measurement and evaluation of finger tapping movements using magnetic sensors. Conf Proc IEEE Eng Med Biol Soc (2008) 1.02
Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol (2009) 1.02